Abstract
Lasmiditan, a selective 5-HT1F receptor agonist, is a harbinger for the novel ditan class of medications for acute migraine treatment. Lasmiditan acti......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
